Your browser doesn't support javascript.
loading
Recent trends in management of noctural enuresis
Scientific Journal of Al-Azhar Medical Faculty [Girls][The]. 2005; 26 (1): 407-415
in English | IMEMR | ID: emr-112386
ABSTRACT
There are many different treatment modalities for nocturnal enuresis options of treatment include behavior modification and Pharmacotherapy. The latter include a scope of drugs like 1-deamino-8-D arginine vasopressin [DDAVP], tricyclic antidepressants anticholinergics and other drugs. Is to study the efficacy of sympathomimetics [e.g. ephedrine] in the treatment of nocturnal enuresis. Two hundred patients selected after complete history, examination, laboratory, radiological and urodynamic study, those patients were given ephedrine HCL according to their age for 2 months and followed for 6 months. Complete dry bed 172 patients [86%] within the first 2 weeks of treatment and the number increased to reach 189 patients [92%] after 2 months of treatment. Eight patients [4%] complained of relapse after 3 months of stoppage of treatment and the number increased after 6 months of stoppage of treatment to 13 patients [6.5%]. Alpha sympathomimetics [ephedrine HCL] is a cheap, simple, easy, effective and safe method for nocturnal enuresis treatment
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Sympathomimetics / Urodynamics / Behavior Therapy / Cholinergic Antagonists / Deamino Arginine Vasopressin / Antidepressive Agents, Tricyclic Limits: Female / Humans / Male Language: English Journal: Sci. J. Al-Azhar Med. Fac. [Girls] Year: 2005

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Sympathomimetics / Urodynamics / Behavior Therapy / Cholinergic Antagonists / Deamino Arginine Vasopressin / Antidepressive Agents, Tricyclic Limits: Female / Humans / Male Language: English Journal: Sci. J. Al-Azhar Med. Fac. [Girls] Year: 2005